In less than four months, Medac Pharma establishes best-in-class
commercial operation with complete suite of cloud customer master,
content management, and multichannel CRM solutions
PLEASANTON, Calif.--(BUSINESS WIRE)--
After filing the 505(b)2 application for Rasuvo® (methotrexate
injection) with the FDA, Medac Pharma needed to quickly build a
commercial foundation for product sales and marketing. Four months
later, Medac Pharma was ready for business with Veeva
Commercial Cloud and fully prepared to take its first product to
market. Veeva Commercial Cloud brings together customer data,
multichannel interactions, and compliant content in a single solution to
enable a fully orchestrated customer experience. Medac Pharma joins a
growing list of life sciences companies establishing end-to-end
commercial operations with Veeva Commercial Cloud.
Starting with a blank slate, Medac Pharma had the rare opportunity to
establish the right technology foundation from the start to maximize
commercial success. The company sought a complete solution that would
meet the needs of sales, marketing, and medical teams and align the
entire organization around the customer. “With Veeva Commercial Cloud,
we gained the full breadth of commercial capabilities in one complete
solution to enable fully coordinated customer engagement across
channels. And with Veeva, we were able to meet our aggressive four-month
deadline and go live successfully,” said
Glenn Tate
, Medac Pharma’s
Senior Director of IT.
Medac Pharma successfully launched Rasuvo, propelled by Veeva Commercial
Cloud, an industry-leading solution designed specifically for the needs
of the life sciences industry. “I knew that I wanted a system that was
proven, fit, and didn’t require extensive customization. It needed to be
streamlined, too, without pieced-together point solutions underpinning
Medac Pharma’s commercial operation,” explained Tate. “Veeva Commercial
Cloud fulfills all of our needs, including important functions like
sample validation. Its flexible, multitenant architecture enables
ongoing innovation and grows with us as we expand into potential new
areas such as oncology.”
Veeva Commercial Cloud includes Veeva CRM to orchestrate customer
engagement across channels, Veeva Vault PromoMats for promotional
materials management, Veeva Network customer master data management
software, and Veeva OpenData’s customer data. It all works in conjunction
to enable timely, compliant, and personalized customer interactions
tightly coordinated across channels. Keryx, Sobi, Kythera, and Medac
Pharma are among the life sciences companies now launching products with
Veeva Commercial Cloud as their commercial foundation.
Medac Pharma President and CEO
Terri Shoemaker
noted, “Veeva Commercial
Cloud provides all of the critical elements of a successful pharma
commercial operation, seamlessly connected in one solution. It allows us
to make the customer central to everything we do. All customer touch
points are channeled through Veeva Commercial Cloud – making it an
integral part of our customer engagement strategy.”
“With Veeva Commercial Cloud, all of our teams see the full history of
customer interactions whether through an email, online detail, phone
call, or face to face. There’s a continuous feedback loop about where
the doctor is in the sales process, which allows for rich insights
aggregated across every step of the customer journey and informed future
engagement,” said
Mike Henrick
, associate director of sales operations
for Medac Pharma. “We’ve also gained digital channels to communicate
with customers on their terms, allowing us to reach more HCPs
efficiently – a critical advantage for a growing organization like ours.”
Uniting industry-leading applications to enable world-class commercial
operations, Veeva Commercial Cloud delivers Medac Pharma the competitive
advantage of proven cloud technology built to meet the evolving needs of
life sciences. “Now more than ever, the life sciences industry requires
the cloud’s inherent scalability and flexibility to remain agile and
competitive in the face of a rapidly changing environment,” said
Paul
Shawah
, vice president of product marketing for Veeva.
Additional Information:
• For more on Veeva Commercial Cloud, please visit: www.veeva.com/commercial-cloud
• Stay updated on the latest Veeva news on LinkedIn: www.linkedin.com/company/veeva-systems
• Follow @veevasystems on Twitter: www.twitter.com/veevasystems
• Like Veeva on Facebook: www.facebook.com/veevasystems
About Medac Pharma: Practicing a Patient-first Philosophy
Medac Pharma, Inc. is a privately held specialty pharmaceutical company
focused on the development, in-licensing and commercialization of
late-stage molecules. The company strives to bring new life to products
and solve everyday patient challenges in autoimmune disease and cancer.
Medac Pharma is the wholly-owned subsidiary of medac GmbH, a well-known
and respected global pharmaceutical company that has been making
scientific and therapeutic discoveries for more than 40 years. For more
information about medac GmbH, please visit www.medac.de.
For complete prescribing information, including Boxed Warning, and
information on Medac Pharma’s CORE Connections program, please visit www.Rasuvo.com.
For more information, please visit www.medacpharma.com.
A Data Boost from Veeva OpenData
Veeva Systems announced Veeva
OpenData last month, as part of Veeva Commercial Cloud. It includes
data and services critical to commercial teams. Central to the offerings
is Veeva OpenData Customer Data, which includes records for millions of
HCPs, HCOs, and affiliations worldwide. Customer records are
continuously updated from authoritative industry sources for the best,
most timely information, including digital profile data crucial to
today’s multichannel engagement. The highest standards of quality and
completeness are ensured through rigorous, automated, and steward-led
validation. Veeva also provides a range of data maintenance services
including cleansing, enhancement, and validation. Veeva OpenData removes
traditional data barriers by making it easy for companies to access and
maximize their customer data with Veeva’s large and growing partner
ecosystem.
About Veeva Systems
Veeva Systems Inc. is a leader in cloud-based software for the global
life sciences industry. Committed to innovation, product excellence, and
customer success, Veeva has more than 275 customers, ranging from the
world's largest pharmaceutical companies to emerging biotechs. Veeva is
headquartered in the San Francisco Bay Area, with offices in Europe,
Asia, and Latin America. For more information, visit www.veeva.com.
Forward-looking Statements
This release contains forward-looking statements, including statements
regarding benefits from the use of Veeva’s solutions, demand for Veeva’s
solutions, and general business conditions. Any forward-looking
statements contained in this press release are based upon Veeva’s
historical performance and its current plans, estimates, and
expectations and are not a representation that such plans, estimates, or
expectations will be achieved. These forward-looking statements
represent Veeva’s expectations as of the date of this press
announcement. Subsequent events may cause these expectations to change,
and Veeva disclaims any obligation to update the forward-looking
statements in the future. These forward-looking statements are subject
to known and unknown risks and uncertainties that may cause actual
results to differ materially. Additional risks and uncertainties that
could affect Veeva’s financial results are included under the captions
“Risk Factors” and “Management’s Discussion and Analysis of Financial
Condition and Results of Operations,” in the company’s filing on Form
10-K for the period ended January 31, 2015, which is available on the
company’s website at www.veeva.com
under the Investors section and on the SEC’s website at www.sec.gov.
Further information on potential risks that could affect actual results
will be included in other filings Veeva makes with the SEC from time to
time.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150521005349/en/
Source: Veeva Systems Inc.